Literature DB >> 20032255

Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.

David R Lonsway1, Laura A Jevitt, James R Uhl, Franklin R Cockerill, Mary E Anderson, Maureen M Sullivan, Barun K De, Jonathan R Edwards, Jean B Patel.   

Abstract

Since some strains of Brucella species may require carbon dioxide for growth, a multilaboratory study was conducted to compare broth microdilution susceptibility results using ambient air (AA) and 5% CO2 incubation conditions. Six antimicrobial agents were tested against 39 Brucella isolates. Aminoglycoside MICs tended to be 1 log2 dilution higher in CO2 than in AA; tetracycline-class MICs to be 1 log2 dilution lower in CO2.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20032255      PMCID： PMC2832407          DOI： 10.1128/JCM.01860-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  In vitro activities of five new antimicrobial agents against Brucella melitensis.

Authors:  I Trujillano-Martín; E García-Sánchez; M J Fresnadillo; J E García-Sánchez; J A García-Rodríguez; I Montes Martínez
Journal:  Int J Antimicrob Agents       Date:  1999-07       Impact factor: 5.283

2.  In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.

Authors:  M Akova; D Gür; D M Livermore; T Kocagöz; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 3.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 4.  Brucellosis: current epidemiology, diagnosis, and management.

Authors:  E J Young
Journal:  Curr Clin Top Infect Dis       Date:  1995

5.  Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.

Authors:  R Lang; R Raz; T Sacks; M Shapiro
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

7.  Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.

Authors:  Philippe Bossi; Anders Tegnell; Agoritsa Baka; Frank Van Loock; Jan Hendriks; Albrecht Werner; Heinrich Maidhof; Georgios Gouvras
Journal:  Euro Surveill       Date:  2004-12-15

8.  Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.

Authors:  M Y Khan; M Dizon; F W Kiel
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

9.  In vitro susceptibility of Brucella melitensis to antibiotics.

Authors:  E Rubinstein; R Lang; B Shasha; B Hagar; L Diamanstein; G Joseph; M Anderson; K Harrison
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 10.  Laboratory exposures to brucellae and implications for bioterrorism.

Authors:  Pablo Yagupsky; Ellen Jo Baron
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883
View more
  1 in total

1.  Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.

Authors:  Alina Tscherne; Enrico Mantel; Talar Boskani; Sylwia Budniak; Mandy Elschner; Antonio Fasanella; Siri L Feruglio; Domenico Galante; Christian G Giske; Roland Grunow; Judit Henczko; Christin Hinz; Wojciech Iwaniak; Daniela Jacob; Agnieszka Kedrak-Jablonska; Veronica K Jensen; Tone B Johansen; Gunnar Kahlmeter; Viviana Manzulli; Erika Matuschek; Falk Melzer; Maria S Nuncio; Joseph Papaparaskevas; Ana Pelerito; Margrete Solheim; Susanne Thomann; Athanasios Tsakris; Tara Wahab; Marcin Weiner; Lothar Zoeller; Sabine Zange
Journal:  Microorganisms       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.